Showing results (11-20 of 148) with videos related to
Sort By:
Pageof 15
Cancers|November 17, 2020
BH3 Mimetics for the Treatment of B-Cell Malignancies-Insights and Lessons from the ClinicVictor S Lin, Zhuo-Fan Xu, David C S Huang, et al.Plos Medicine|November 2, 2007
Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimeticsMark S Cragg, Junya Kuroda, Hamsa Puthalakath, et al.Cancers|October 28, 2023
Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against CancersJiaxuan Xu, Xiaoqing Dong, David C S Huang, et al.Therapeutic Advances in Hematology|February 3, 2016
Current challenges and novel treatment strategies in double hit lymphomasMary Ann Anderson, Alpha Tsui, Meaghan Wall, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2010
The BH3-mimetic ABT-737 induces mast cell apoptosis in vitro and in vivo: potential for therapeuticsMats Karlberg, Maria Ekoff, David C S Huang, et al.Journal of Leukocyte Biology|July 2, 2011
Evaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritisKate E Lawlor, Scott D Smith, Annemarie van Nieuwenhuijze, et al.Frontiers in Oncology|April 23, 2024
Co-operation of MCL-1 and BCL-X<sub>L</sub> anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicityDaria Galas-Filipowicz, Selina J Chavda, Jia-Nan Gong, et al.Blood|May 21, 2005
FADD and caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cellsMarc Pellegrini, Sue Bath, Vanessa S Marsden, et al.The Journal of Biological Chemistry|November 20, 2004
Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligandsCatherine L Day, Lin Chen, Sarah J Richardson, et al.Organic Letters|March 7, 2013
Synthesis of biotinylated episilvestrol: highly selective targeting of the translation factors eIF4AI/IIJennifer M Chambers, Lisa M Lindqvist, Andrew Webb, et al.Pageof 15